期刊文献+

脑梗死合并糖尿病患者血清sICAM-1含量的研究 被引量:14

A study on the levels of serum sICAM-1 in the patients with cerebral infarction
原文传递
导出
摘要 目的 探讨合并糖尿病的脑梗死患者血清中可溶性细胞间粘附分子 (sICAM - 1)的变化及临床意义。方法 采用双抗体 (ELISA)法测定了 5 0例合并糖尿病的脑梗死患者血清中sICAM - 1的含量 ,并与30例不合并糖尿病的脑梗死患者及正常人 30例比较。结果 合并糠尿病的脑梗死患者血清sICAM - 1的水平明显高于正常人组 (P <0 .0 1) ,也高于单纯脑梗死患者 (P <0 .0 5 )。结论 糖尿病病人sICAM - Objective To characterize the pattern of release of soluble intercellular adhesion molecule-1(sICAM-1) in the cases of cerebral infarction with diabetes.Methods the level of serum sICAM-1 was measured by two-layer antibody sandwich enzyme-linked immunosovbent assay(ELISA) in 50 cases of acute cerebral infarction with diabetes, 30 patients with acute cerebral infarction and 30 normal controls.Results The level of serum sICAM-1 in cases of cerebral infarction with diabetes was higher than that of the patients suffered from cerebral infarction and was much higher than that of normal controls.Conclusion In the patients with diabetes the level of sICAM-1 increases.
出处 《卒中与神经疾病》 2002年第1期32-33,共2页 Stroke and Nervous Diseases
关键词 脑梗死 可溶性粘附分子 糖尿病 含量 血清 Cerebral infarction sICAM-1 Diabetes
  • 相关文献

参考文献1

共引文献14

同被引文献122

引证文献14

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部